Track the Elevance Health, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Elevance Health, Inc. has published 127 insider filings. Market capitalisation: €80.9bn. The latest transaction was disclosed on 17 July 2026 (Acquisition). Among the most active insiders: BOUDREAUX GAIL. The full history is openly available.
127
Insider Decl.
n/a
Thresholds
€3m
6 ops.
Buy Volume
€26m
22 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Elevance Health, Inc. Buy (bullish), based on 21 analysts. Average price target: US$449.10.
39Σ signal
Buys €3m€26m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,845 of 29,062 companies
51.4
score / 100
Value
58
Quality
45
FCF yld3.7%
Earn yld6.6%
EV/EBITDA14.1x
ROE11%
Gross mgn·
Net mgn2.8%
Debt/EBITDA3.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,421 shares@ US$294.076.0% of flowCommon StockSEC:0001743548-26-000002:0
25 of 127 declarations
关于 Elevance Health, Inc.
Elevance Health, Inc. 是一家领先的美国健康保险公司和医疗保健服务公司,在纽约证券交易所上市,股票代码为 ELV。该公司前身为 Anthem,后更名为 Elevance Health,以更好地反映其超越传统保险的更广泛业务模式。公司总部位于印第安纳州印第安纳波利斯,主要在美国运营,将管理式健康福利与护理交付支持、药房服务、行为健康和数据驱动的医疗保健解决方案相结合。
该集团服务于多元化的客户群,包括雇主、个人、政府资助的成员以及根据州合同和项目参与情况的医疗保险/医疗补助人群。其业务通常通过两个主要平台来描述:健康福利(Health Benefits),涵盖核心保险和管理式医疗特许经营权;以及 Carelon,提供护理协调、药房、行为健康和分析能力的服務部门。这种结构使 Elevance Health 既能获得保费收入,又能获得以服务为导向、可能更具可扩展性的医疗保健工作流程。
从竞争角度来看,Elevance Health 位居美国管理式医疗机构的顶尖行列。其市场地位得益于规模、广泛的供应商关系、深入的雇主和公共项目渗透,以及日益整合的医疗保健管理方法。该公司还大力投资数字工具,例如 Sydney Health 应用程序和虚拟协助功能,以简化访问、改善会员导航并加强整个护理过程中的参与度。同时,它还推动基于价值的护理合作关系和供应商认可计划,以提高质量和控制成本。
近期发展表明,该公司专注于执行、技术和成本纪律。在2025年第二季度,Elevance Health 报告了运营收入增长,并上调了全年调整后每股收益指引,同时指出某些业务线的医疗成本趋势较高。2026年,该公司继续强调数字化扩张、供应商网络计划以及旨在加强其平台执行力的领导层变动。对于讲法语的投资者而言,ELV 仍然是具有吸引力结构特征的防御性美国医疗保健股,但它也对医疗成本通胀、报销趋势和美国的监管发展敏感。